Form 6-K TARO PHARMACEUTICAL INDU For: May 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
Taro Pharma (TARO) Posts Inline Q4 Breakeven Loss
May 27, 2015 7:29 AM EDTTaro Pharma (NYSE: TARO) reported Q4 EPS of $0.00, versus $0.00 reported last year. Revenue for the quarter came in at $244.2 million, versus $881.79 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More


